Medplus Health Services Limited — Important, 30-12-2024: General Updates
30-12-2024 | 05:46 pm
30-12-2024 | 05:46 pm
Optival Health Solutions, a material subsidiary of MedPlus Health Services, has received a suspension order for drug licenses affecting multiple stores in Karnataka and Maharashtra. The company faces a potential revenue loss estimated at approximately ₹1.37 lakh from a one-day suspension in Karnataka. In Maharashtra, potential losses include ₹1.39 lakh and ₹2.04 lakh from five-day suspensions at two stores, and losses of ₹0.42 lakh, ₹1.20 lakh, and ₹0.50 lakh from three-day suspensions at three separate stores. These developments could impact MedPlus's operational stability and revenue streams, warranting close monitoring for any further implications on business performance.
No comments yet. Be the first to comment!
